Back to Results
First PageMeta Content
Biology / Science / Genomics / Bioinformatics / Chemical pathology / Quantitative proteomics / Biomarker / Selected reaction monitoring / Agilent Technologies / Chemistry / Mass spectrometry / Proteomics


Agilent Technologies and Applied Proteomics Will Collaborate to Maximize Capabilities of Highly Multiplexed Protein Assays SANTA CLARA and SAN DIEGO, Calif., March 7, 2013 Agilent Technologies Inc. (NYSE:A) and Applied P
Add to Reading List

Document Date: 2015-03-12 18:39:29


Open Document

File Size: 188,94 KB

Share Result on Facebook

City

SANTA CLARA / SAN DIEGO / /

Company

Agilent Technologies Agilent Technologies Inc. / Applied Proteomics Will / Agilent Technologies Inc. / Infinity LC / Applied Proteomics Will Collaborate / Applied Proteomics Inc. / /

Currency

USD / /

Event

Business Partnership / /

IndustryTerm

instrumentation technologies / faster computing / personalized medicine applications / important applications / liquid-handling technologies / workflow solutions / software platforms / electronics / proteome applications / proteomics platform solution / chemical analysis / /

MedicalCondition

disease / human diseases / MS / /

Person

John E. Blume / Can Ozbal / /

Position

chief science officer / director / director of RapidFire business / /

ProvinceOrState

California / /

Technology

proteomics / instrumentation technologies / liquid-handling technologies / /

URL

www.agilent.com / www.agilent.com/go/news / www.appliedproteomics.com / /

SocialTag